ARCHIVES

ORI Finds Misconduct By CIT Professor

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

November 18, 2011

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

Clinical Research: Cooperative Groups Form Coalition to Advance Trials

November 14, 1997

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

Funding Opportunities: NCI Grant Supplements For Mammalian Models

October 22, 1999

Also in this 8-page issue: Dana-Farber opens center for advanced cancer science.

April 23, 2004